Responses
Correspondence
Comment on l’Ami et al titled ’Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial'
Compose a Response to This Article
Other responses
No responses have been published for this article.